110 related articles for article (PubMed ID: 38879502)
1. Increase in wasteosomes (corpora amylacea) in frontotemporal lobar degeneration with specific detection of tau, TDP-43 and FUS pathology.
Alsina R; Riba M; Pérez-Millan A; Borrego-Écija S; Aldecoa I; Romera C; Balasa M; Antonell A; Lladó A; Compta Y; Del Valle J; Sánchez-Valle R; Pelegrí C; Molina-Porcel L; Vilaplana J
Acta Neuropathol Commun; 2024 Jun; 12(1):97. PubMed ID: 38879502
[TBL] [Abstract][Full Text] [Related]
2. Neuronal cytoplasmic inclusions in tau, TDP-43, and FUS molecular subtypes of frontotemporal lobar degeneration share similar spatial patterns.
A Armstrong R
Folia Neuropathol; 2017; 55(3):185-192. PubMed ID: 28984110
[TBL] [Abstract][Full Text] [Related]
3. Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies.
Koga S; Murakami A; Soto-Beasley AI; Walton RL; Baker MC; Castanedes-Casey M; Josephs KA; Ross OA; Dickson DW
Acta Neuropathol Commun; 2023 Jul; 11(1):109. PubMed ID: 37415197
[TBL] [Abstract][Full Text] [Related]
4. Aberrant interaction between FUS and SFPQ in neurons in a wide range of FTLD spectrum diseases.
Ishigaki S; Riku Y; Fujioka Y; Endo K; Iwade N; Kawai K; Ishibashi M; Yokoi S; Katsuno M; Watanabe H; Mori K; Akagi A; Yokota O; Terada S; Kawakami I; Suzuki N; Warita H; Aoki M; Yoshida M; Sobue G
Brain; 2020 Aug; 143(8):2398-2405. PubMed ID: 32770214
[TBL] [Abstract][Full Text] [Related]
5. Concurrent tau pathologies in frontotemporal lobar degeneration with TDP-43 pathology.
Koga S; Zhou X; Murakami A; Fernandez De Castro C; Baker MC; Rademakers R; Dickson DW
Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12778. PubMed ID: 34823271
[TBL] [Abstract][Full Text] [Related]
6. Abundant copathologies of polyglucosan bodies, frontotemporal lobar degeneration with TDP-43 inclusions and ageing-related tau astrogliopathy in a family with a GBE1 mutation.
Uemura MT; Suh ER; Robinson JL; Brunden KR; Grossman M; Irwin DJ; Lee VM; Trojanowski JQ; Lee EB; Van Deerlin VM
Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12865. PubMed ID: 36456471
[TBL] [Abstract][Full Text] [Related]
7. FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration.
Urwin H; Josephs KA; Rohrer JD; Mackenzie IR; Neumann M; Authier A; Seelaar H; Van Swieten JC; Brown JM; Johannsen P; Nielsen JE; Holm IE; ; Dickson DW; Rademakers R; Graff-Radford NR; Parisi JE; Petersen RC; Hatanpaa KJ; White CL; Weiner MF; Geser F; Van Deerlin VM; Trojanowski JQ; Miller BL; Seeley WW; van der Zee J; Kumar-Singh S; Engelborghs S; De Deyn PP; Van Broeckhoven C; Bigio EH; Deng HX; Halliday GM; Kril JJ; Munoz DG; Mann DM; Pickering-Brown SM; Doodeman V; Adamson G; Ghazi-Noori S; Fisher EM; Holton JL; Revesz T; Rossor MN; Collinge J; Mead S; Isaacs AM
Acta Neuropathol; 2010 Jul; 120(1):33-41. PubMed ID: 20490813
[TBL] [Abstract][Full Text] [Related]
8. Frequency of ubiquitin and FUS-positive, TDP-43-negative frontotemporal lobar degeneration.
Seelaar H; Klijnsma KY; de Koning I; van der Lugt A; Chiu WZ; Azmani A; Rozemuller AJ; van Swieten JC
J Neurol; 2010 May; 257(5):747-53. PubMed ID: 19946779
[TBL] [Abstract][Full Text] [Related]
9. Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology.
Giannini LAA; Peterson C; Ohm D; Xie SX; McMillan CT; Raskovsky K; Massimo L; Suh E; Van Deerlin VM; Wolk DA; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
Acta Neuropathol Commun; 2021 Feb; 9(1):30. PubMed ID: 33622418
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNAs in TDP-43 and FUS/TLS-related frontotemporal lobar degeneration (FTLD).
Lourenco GF; Janitz M; Huang Y; Halliday GM
Neurobiol Dis; 2015 Oct; 82():445-454. PubMed ID: 26220395
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of the behavioural variant of frontotemporal dementia that are useful for predicting underlying pathological subtypes of frontotemporal lobar degeneration.
Kobayashi Z; Arai T; Kawakami I; Yokota O; Hosokawa M; Oshima K; Niizato K; Shiraishi A; Akiyama H; Mizusawa H
Psychogeriatrics; 2018 Jul; 18(4):307-312. PubMed ID: 30133939
[TBL] [Abstract][Full Text] [Related]
12. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
[TBL] [Abstract][Full Text] [Related]
13. Nuclear carrier and RNA-binding proteins in frontotemporal lobar degeneration associated with fused in sarcoma (FUS) pathological changes.
Davidson YS; Robinson AC; Hu Q; Mishra M; Baborie A; Jaros E; Perry RH; Cairns NJ; Richardson A; Gerhard A; Neary D; Snowden JS; Bigio EH; Mann DM
Neuropathol Appl Neurobiol; 2013 Feb; 39(2):157-65. PubMed ID: 22497712
[TBL] [Abstract][Full Text] [Related]
14. White matter imaging helps dissociate tau from TDP-43 in frontotemporal lobar degeneration.
McMillan CT; Irwin DJ; Avants BB; Powers J; Cook PA; Toledo JB; McCarty Wood E; Van Deerlin VM; Lee VM; Trojanowski JQ; Grossman M
J Neurol Neurosurg Psychiatry; 2013 Sep; 84(9):949-55. PubMed ID: 23475817
[TBL] [Abstract][Full Text] [Related]
15. Psychiatric symptoms of frontotemporal dementia and subcortical (co-)pathology burden: new insights.
Scarioni M; Gami-Patel P; Peeters CFW; de Koning F; Seelaar H; Mol MO; van Swieten JC; ; Rozemuller AJM; Hoozemans JJM; Pijnenburg YAL; Dijkstra AA
Brain; 2023 Jan; 146(1):307-320. PubMed ID: 35136978
[TBL] [Abstract][Full Text] [Related]
16. Novel types of frontotemporal lobar degeneration: beyond tau and TDP-43.
Mackenzie IR; Neumann M; Cairns NJ; Munoz DG; Isaacs AM
J Mol Neurosci; 2011 Nov; 45(3):402-8. PubMed ID: 21603977
[TBL] [Abstract][Full Text] [Related]
17. Plasma Tau and Neurofilament Light in Frontotemporal Lobar Degeneration and Alzheimer Disease.
Illán-Gala I; Lleo A; Karydas A; Staffaroni AM; Zetterberg H; Sivasankaran R; Grinberg LT; Spina S; Kramer JH; Ramos EM; Coppola G; La Joie R; Rabinovici GD; Perry DC; Gorno-Tempini ML; Seeley WW; Miller BL; Rosen HJ; Blennow K; Boxer AL; Rojas JC
Neurology; 2021 Feb; 96(5):e671-e683. PubMed ID: 33199433
[TBL] [Abstract][Full Text] [Related]
18. Distinct pathological subtypes of FTLD-FUS.
Mackenzie IR; Munoz DG; Kusaka H; Yokota O; Ishihara K; Roeber S; Kretzschmar HA; Cairns NJ; Neumann M
Acta Neuropathol; 2011 Feb; 121(2):207-18. PubMed ID: 21052700
[TBL] [Abstract][Full Text] [Related]
19. Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease.
Luty AA; Kwok JB; Dobson-Stone C; Loy CT; Coupland KG; Karlström H; Sobow T; Tchorzewska J; Maruszak A; Barcikowska M; Panegyres PK; Zekanowski C; Brooks WS; Williams KL; Blair IP; Mather KA; Sachdev PS; Halliday GM; Schofield PR
Ann Neurol; 2010 Nov; 68(5):639-49. PubMed ID: 21031579
[TBL] [Abstract][Full Text] [Related]
20. Tau Rather than TDP-43 Proteins are Potential Cerebrospinal Fluid Biomarkers for Frontotemporal Lobar Degeneration Subtypes: A Pilot Study.
Kuiperij HB; Versleijen AA; Beenes M; Verwey NA; Benussi L; Paterlini A; Binetti G; Teunissen CE; Raaphorst J; Schelhaas HJ; Küsters B; Pijnenburg YA; Ghidoni R; Verbeek MM
J Alzheimers Dis; 2017; 55(2):585-595. PubMed ID: 27662293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]